Silence Therapeutics Statistics
Total Valuation
SLN has a market cap or net worth of $873.92 million. The enterprise value is $680.41 million.
| Market Cap | 873.92M |
| Enterprise Value | 680.41M |
Important Dates
The next estimated earnings date is Wednesday, August 14, 2024, before market open.
| Earnings Date | Aug 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SLN has 48.39 million shares outstanding. The number of shares has increased by 10.24% in one year.
| Shares Outstanding | 48.39M |
| Shares Change (YoY) | +10.24% |
| Shares Change (QoQ) | +2.45% |
| Owned by Insiders (%) | 16.94% |
| Owned by Institutions (%) | 61.34% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 25.81 |
| Forward PS | n/a |
| PB Ratio | 5.56 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 20.10 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.82, with a Debt / Equity ratio of 0.00.
| Current Ratio | 12.82 |
| Quick Ratio | 11.35 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.81 |
Financial Efficiency
Return on equity (ROE) is -80.70% and return on invested capital (ROIC) is -33.51%.
| Return on Equity (ROE) | -80.70% |
| Return on Assets (ROA) | -29.20% |
| Return on Capital (ROIC) | -33.51% |
| Revenue Per Employee | $310,598 |
| Profits Per Employee | -$410,950 |
| Employee Count | 109 |
| Asset Turnover | 0.22 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -7.69M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +203.53% in the last 52 weeks. The beta is 1.33, so SLN's price volatility has been higher than the market average.
| Beta (5Y) | 1.33 |
| 52-Week Price Change | +203.53% |
| 50-Day Moving Average | 21.07 |
| 200-Day Moving Average | 17.61 |
| Relative Strength Index (RSI) | 34.99 |
| Average Volume (20 Days) | 164,203 |
Short Selling Information
| Short Interest | 658,436 |
| Short Previous Month | 600,674 |
| Short % of Shares Out | 1.36% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 7.29 |
Income Statement
In the last 12 months, SLN had revenue of $33.86 million and -$44.79 million in losses. Loss per share was -$1.17.
| Revenue | 33.86M |
| Gross Profit | 23.36M |
| Operating Income | -52.81M |
| Pretax Income | -52.04M |
| Net Income | -44.79M |
| EBITDA | -47.69M |
| EBIT | -48.27M |
| Loss Per Share | -$1.17 |
Balance Sheet
The company has $193.87 million in cash and $351,553 in debt, giving a net cash position of $193.52 million or $4.00 per share.
| Cash & Cash Equivalents | 193.87M |
| Total Debt | 351,553 |
| Net Cash | 193.52M |
| Net Cash Per Share | $4.00 |
| Equity (Book Value) | 157.25M |
| Book Value Per Share | 3.25 |
| Working Capital | 212.65M |
Cash Flow
In the last 12 months, operating cash flow was -$49.74 million and capital expenditures -$22,845, giving a free cash flow of -$49.76 million.
| Operating Cash Flow | -49.74M |
| Capital Expenditures | -22,845 |
| Free Cash Flow | -49.76M |
| FCF Per Share | -$1.26 |
Margins
Gross margin is 69.01%, with operating and profit margins of -155.99% and -132.31%.
| Gross Margin | 69.01% |
| Operating Margin | -155.99% |
| Pretax Margin | -153.71% |
| Profit Margin | -132.31% |
| EBITDA Margin | -140.87% |
| EBIT Margin | -142.58% |
| FCF Margin | -146.98% |
Dividends & Yields
SLN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.24% |
| Shareholder Yield | -10.24% |
| Earnings Yield | -5.13% |
| FCF Yield | -5.69% |
Analyst Forecast
The average price target for SLN is $61.50, which is 240.53% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $61.50 |
| Price Target Difference | 240.53% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SLN has an Altman Z-Score of 4.19 and a Piotroski F-Score of 3.
| Altman Z-Score | 4.19 |
| Piotroski F-Score | 3 |